News from NPR

Patients whose blood cancers have failed to respond to repeated rounds of chemotherapy may be candidates for a new type of gene therapy that could send their cancers into remission for years. But the two approved therapies, with price tags of hundreds of thousands of dollars, have roiled the insurance approval process, leading to delays and, in some cases, denials of coverage, clinicians and analysts say.

New charges against a woman who tried to build bridges between the Russian government and American political leaders via the National Rifle Association delivered a breakthrough in understanding one aspect of the attack on the 2016 election: "infiltration."

After months of questions and speculation as to how or whether the NRA connection might have worked, prosecutors have proffered an answer: The Russian woman, Maria Butina, was the intermediary between Russian government officials and Americans, both in the NRA and elsewhere in politics, according to court documents.

Netflix says its faulty forecasting caused it to miss its target for new subscribers, falling short by more than a million even as it reported quarterly earnings that beat analysts' expectations.

Given the attitude with which President Trump has greeted all news of the Russian interference in the 2016 election, his performance in Helsinki on Monday should have come as no surprise.

And yet there was surprise — even shock — when the president of the United States stood on stage alongside Russian President Vladimir Putin and accepted the former KGB officer's denials regarding that interference.

Pages